
Spider venom heart drug moves to human clinical trials
A project to develop a drug to treat heart attack and protect donor hearts will move to human clinical trials, after receiving $17.8 million in funding from the Medical Research Future Fund (MRFF). Professor Glenn King from the University of Queensland’s (UQ) Institute for Molecular Bioscience… Read More

